Virginia Kaklamani MD
Breast Cancer, Hematologic Oncology
Professor of Medicine at University of Texas Health Science Center San Antonio
Join to View Full Profile
7979 Wurzbach Rd FL Z5San Antonio, TX 78229
Phone+1 210-450-2872
Fax+1 210-450-0407
Dr. Kaklamani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2000 - 2003
Newton-Wellesley HospitalResidency, Internal Medicine, 1997 - 2000
University of AthensClass of 1996
Certifications & Licensure
TX State Medical License 2014 - 2025
IL State Medical License 2000 - 2017
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2002 Jul 01
- Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Start of enrollment: 2006 May 04
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- Goserelin 3-month depot shows non-inferiority to the monthly formulation in U.S. patients with premenopausal breast cancer: a real-world evidence study.Kelly E McCann, Noran Osman, Joan Cannon, Lonnie Brent, Yuexi Wang
Breast Cancer Research and Treatment. 2025-06-01 - Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors.Ranjit Banwait, Heidi Ko, Joel Michalek, Qianqian Liu, Kate Lathrop
International Journal of Cancer. 2025-04-15 - Genomic and transcriptomic landscape of HER2-low breast cancer.Rani Bansal, Tolulope Adeyelu, Andrew Elliott, Phillip Walker, Matias A Bustos
Breast Cancer Research and Treatment. 2025-01-01
Lectures
- Genomic stratification with BCI of ER+ early breast cancer patients with limited long-term risk of breast cancer death.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Axillary node metastases with occult primary breast cancerKaklamani V, Gradishar WJ
http://www.uptodate.com/contents/axillary-node-metastases-with-occult-primary-breast-cancer
UpToDate, Wolters Kluwer Health - 2012-08-07
Press Mentions
Can Imlunestrant Change the Future of Breast Cancer Treatment? Insights from SABCS with Virginia Kaklamani, MDFebruary 8th, 2025- Adjuvant Tamoxifen Reduces 15-Year Risk of Recurrence in ‘Good Risk’ DCIS Without Radiation TherapyJanuary 10th, 2025
- CDK 4/6 Blocker Prolongs Survival in HER2+ Metastatic Breast CancerJanuary 9th, 2025
- Join now to see all
Professional Memberships
- Member
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
